Arsenic and arsenic containing compounds are human carcinogens. Exposure to arsenic occurs occupationally in several industries, including mining, pesticide, pharmaceutical, glass and microelectronics, as well as environmentally from both industrial and natural sources. Inhalation is the principal route of arsenic exposure in occupational settings, while ingestion of contaminated drinking water is the predominant source of significant environmental exposure globally. Drinking water contamination by arsenic remains a major public health problem. Acute and chronic arsenic exposure via drinking water has been reported in many countries of the world, where a large proportion of drinking water is contaminated with high concentrations of arsenic. General health effects that are associated with arsenic exposure include cardiovascular and peripheral vascular disease, developmental anomalies, neurologic and neurobehavioural disorders, diabetes, hearing loss, portal fibrosis, hematologic disorders (anemia, leukopenia and eosinophilia) and multiple cancers: significantly higher standardized mortality rates and cumulative mortality rates for cancers of the skin, lung, liver, urinary bladder, kidney, and colon in many areas of arsenic pollution. Although several epidemiological studies have documented the sources of exposure and the global impact of arsenic contamination, the mechanisms by which arsenic induces health effects, including cancer, are not well characterized. Further research is needed to provide a better understanding of the pathobiology of arsenic-induced diseases and to better define the toxicologic pathology of arsenic in various organ systems. In this review, we provide and discuss the underlying pathology and nature of arsenic-induced lesions. Such information is critical for understanding the magnitude of health effects associated with arsenic exposure throughout the world.
INTRODUCTION
Arsenic is a ubiquitous element detected in low concentrations in virtually all environmental media. Arsenic compounds represent a concern to environmental and occupational health when their presence in the environment increases due to natural or anthropogenic sources (2) . More than 80% of arsenic compounds are used to manufacture products with agricultural applications such as insecticides, herbicides, fungicides, algicides, sheep dips, wood preservatives, dye-stuffs, and medicines for the eradication of tapeworms in sheep and cattle (109) . Arsenic compounds have been used for at least a century in the treatment of syphilis, yaws, amoebic dysentery, and trypanosomaiasis. In 1887, Hutchinson first described skin cancer in patients treated with arsenic-containing medication for psoriasis and other skin conditions (69, 70) . Arsenical drugs are still used in treating certain tropical diseases such as African sleeping sickness and amoebic dysentery, and in veterinary medicine to treat parasitic diseases, including filariasis in dogs and black head in turkeys and chickens (109) . Recently, arsenic has been used as an anticancer agent in the treatment of acute promeylocytic leukemia, and its therapeutic action has been attributed to the induction of programmed cell death (apoptosis) in leukemia cells (128) .
A large number of people are exposed to arsenic chronically throughout the world. Exposure to arsenic occurs via the oral route (ingestion), inhalation, dermal contact, and the parenteral route to some extent (2) . Arsenic is found naturally, its concentrations in air in remote locations (away from human releases) range from 1 to 3 ng/m 3 , whereas concentrations in cities may range from 20 to 100 ng/m 3 . In water, the concentrations of arsenic are usually less than 10 µg/L, although higher concentrations can occur near natural mineral deposits or man made sources. Natural levels of arsenic in soil usually range from 1 to 40 mg/kg, but pesticide application or waste disposal can produce much higher values. Arsenic is also found in many foods at concentrations ranging from 20 to 140 ng/kg (2) .
Diet, for most individuals is the largest source of exposure, with an average intake of about 50 µg per day from food. Intake from air, water, and soil are usually much smaller, 575 but exposure from these media may become significant in areas of arsenic contamination. Workers who produce or use arsenic compounds in such occupations as vineyards, ceramics, glass-making, smelting, pharmaceuticals, refining of metallic ores, pesticide manufacturing and application, wood preservation, or semiconductor manufacturing can be exposed to substantially higher levels of arsenic (58) .
Hazardous waste sites (HWS) constitute another possible source of human exposure to arsenic. This element has been identified at 781 sites of the 1,300 HWS that have been proposed for inclusion on the national priority list (59) . Exposure at these sites may occur by a variety of pathways, including of dusts in air, ingestion of contaminated water or soil, or through the food chain.
Analyzing the toxic effects of arsenic is complicated because the toxicity varies according to its oxidation state, its solubility (95, 161) and in many different inorganic and organic compounds. Several studies have indicated that the toxicity of arsenic depends on the exposure dose, frequency and duration, the biological species, age, and gender, as well as on individual susceptibilities, genetic and nutritional factors (26) . Most cases of human toxicity from arsenic have been associated with exposure to inorganic arsenic. Inorganic trivalent arsenite (As III ) is 2-10 times more toxic than pentavalent arsenate (As V ) (76) . Gallium arsenide (GaAs) is another inorganic arsenic compound of potential human health concern because of its widespread use in the microelectronics industry (110). Contamination with high levels of arsenic is of concern because arsenic can cause a number of human health effects, including cancer (112) . Interest in the toxicity of arsenic has been heightened by recent reports of large populations in West Bengal, Bangladesh, Thailand, Inner Mongolia, Taiwan, China, Mexico, Argentina, Chile, Finland, and Hungary that have been exposed to high concentrations of arsenic in their drinking water and are displaying various clinico-pathological conditions, the major effects being skin alterations and skin cancer besides cardiovascular and peripheral vascular disease, developmental anomalies, neurologic and neurobehavioural disorders, diabetes, hearing loss, portal fibrosis, hematologic disorders (anemia, leukopenia, and eosinophilia), and carcinoma (23, 101) . Several epidemiological studies have reported a strong association between arsenic exposure and increased risks of both carcinogenic and systemic health effects (112) . In this paper, we provide and discuss important information about the molecular mechanisms of arsenic toxicity, as well as the health effects associated with arsenic exposure.
MECHANISMS OF ARSENIC TOXICITY
AND CARCINOGENICITY One of the mechanisms by which arsenic exerts its toxic effect is through impairment of cellular respiration by the inhibition of various mitochondrial enzymes, and the uncoupling of oxidative phosphorylation. Most toxicity of arsenic results from its ability to interact with sulfhydryl groups of proteins and enzymes, and to substitute phosphorous in a variety of biochemical reactions (51) . Arsenic in vitro reacts with protein sulfhydryl groups to inactivate enzymes, such as dihydrolipoyl dehydrogenase and thiolase, thereby producing inhibited oxidation of pyruvate and betaoxidation of fatty acids (12) .
Tests for genotoxicity have indicated that arsenic compounds inhibit DNA repair, and induce chromosomal aberrations, sister-chromatid exchanges, and micronuclei formation in both human and rodent cells in culture (11, 57, 73, 164) and in cells of exposed humans (159) . The mechanism of genotoxicity is not known, but may be due to the ability of arsenate to inhibit DNA replicating or repair enzymes, or the ability of arsenate to act as a phosphate analog (88) . Reversion assays with Salmonella typhimurium fails to detect mutations that are induced by arsenic compounds. Although arsenic compounds are generally perceived as weak mutagens in bacterial and animal cells, they exhibit clastogenic properties in many cell types in vivo and in vitro (57, 72, 73, 164) . In the absence of animal models, in vitro cell transformation studies become a useful means of obtaining information on the carcinogenic mechanisms of arsenic toxicity. Arsenic and arsenical compounds are toxic to and induce morphologic transformations of Syrian hamster embryo (SHE) cells as well as mouse C3H10T1/2 cells and BALB/3T3 cells (79, 82, 146) . Based on the comet assay, it has been reported that arsenic trioxide induces DNA damage in human lymphocytes (132) . Arsenical compounds have also been shown to induce gene amplification, arrest cells in mitosis, inhibit DNA repair, and induce expression of the c-fos gene and the oxidative stress protein heme oxygenase in mammalian cells (49, 107, 108, 127) . They have been implicated as promoters and comutagens for a variety of toxic agents (68) .
The major metabolic pathway for inorganic arsenic in humans is methylation. This pathway of arsenic metabolism and excretion is presented in Figure 1 . Most of the inorganic arsenic [As (III) and As (V)] is metabolized to monomethylarsonic acid [MMA (V)] and dimethylarsinic acid [DMA (V)] before excretion in the urine. Methylation of arsenic involves a two-electron reduction of pentavalent [eg, As (V) & MMA (V)] to trivalent [eg, As (III) & MMA (III)] arsenic species followed by the transfer of a methyl group from a methyl donor, such as S-adenosylmethionine (35, 112, 149) . This methylation mechanism has been widely accepted, and the metabolites MMA (V) and DMA (V) have been consistently observed in human urine. A key intermediate for the methylation of MMA (V) to DMA (V) is the MMA (III) species. Several studies have indicated the presence of MMA (III) species in rat liver cytosol and hepatocytes, and demonstrated the important effects of the methylated trivalent arsenic species in biological systems (5, 89, 120, 142-145, 174, 175) .
The generally held view of arsenic carcinogenesis in the past was that arsenite was the most likely cause of carcinogensis and that methylation of arsenic species was a detoxification pathway. Several authors thought that methylation of arsenic was of great importance in minimizing arsenic's toxicity and/or carcinogenicity (75) . The present view of arsenic carcinogenesis is that there are many possible chemical forms of arsenic that may be causal in carcinigenesis and that methylation of arsenic may be a toxification, not a detoxification, pathway. A great amount of evidence has accumulated, in a short period of time about toxification pathway of methylated arsenic.
MMA (III) has been found in urine of humans exposed to arsenic without (5) and with concomitant treatment with chelators (6) . Some of the biological activities that MMA (III) is known to possess in various experimental systems FIGURE 1.-Metabolism of arsenic in the liver: As V → As III (Reduction); As III → As V (Oxidation); As III → MMAs V (Methylation); SAM (S-Adenosylmethionine); SAH (S-Adenosylhomocysteine); GSH (Glutathione reduced); GSSG (Glutathione oxidized).
include enzyme inhibition (89, 144) , cell toxicity (120) , and genotoxicity (96) . MMA (III) is an excellent choice as a cause of arsenic carcinogenesis.
DMA (III) has been detected in human urine of arsenicexposed humans administered a chelator (81) . In a study of hamsters given arsenate (130) , substantial hepatic concentrations of trivalent MMA and DMA were found in addition to the expected pentavalent MMA and DMA. The capacity to separate the trivalent forms of the methylated arsenic species from the pentavalent forms has just been developed (37, 81, 130) . Wei et al (167) demonstrated DMA to be a carcinogen for the rat urinary bladder and suggested that DMA exposure may be relevant to the carcinogenic risk of inorganic arsenic in humans. Diverse genetic alterations observed in DMAinduced urinary bladder tumors imply that multiple genes are involved in stages of DMA-induced tumor development (167) .
Few data are currently available on the tissue concentrations of trivalent methylated species. Some of the biological activities that DMA (III) is known to possess in various experimental systems include enzyme inhibition (89, 144) , cell toxicity (120), genotoxicity, and clastogenecity (81) .
Trimethylarsinic acid [TMA (III)] may be produced from trimethylarsine oxide [TMAO] by reduction. Data from one group suggest that only rats may have relatively high levels of TMAO in their urine. A molecule of TMA (III) possesses no ionizable hydroxyl groups to limit the ability of the trivalent arsenic species to interact with DNA. TMA (III) may exist in higher concentrations in rat tissues than in human tissues. Interaction of novel information on the formation, fate, and actions of the methylated arsenicals in humans and other species will reduce some of the uncertainties in the risk assessment for arsenic.
Exposure to arsenic is considered a major public health concern, particularly because of its clear carcinogenic potential (112) . However, the molecular mechanism by which and the dose at which it causes cancer are still unclear. In risk assessment of environmental arsenic, it is important to know and to utilize both the mode of carcinogenic action and the shape of the dose-response curve at low environmental arsenic concentrations. Although much progress has been recently made in the area of arsenic's possible mode(s) of carcinogenic action, a scientific concensus has not yet been reached. Kitchin (75) in his review discussed 9 different possible modes of action of arsenic carcinogenesis: induced chromosomal abnormalities (49, 88, 94, 166) , oxidative stress (3, 53, 90, 98, 165, 171, 172) , altered DNA repair (1, 67, 88) , altered DNA methylation patterns (97, 179, 180) , altered growth factors (47, 136, 160) , enhanced cell proliferation (8, 17, 121, 165, 170) , promotion/progression (33, 55, 104) , suppression of p53 (14, 20, 54, 65, 129) , gene amplification (83) . Presently, 3 modes (chromosomal abnormality, oxidative stress, and altered growth factors) for arsenic carcinogenesis have a degree of positive evidence, both in experimental systems (animal and human cells) and in human tissues. The remaining possible modes of carcinogenic action for arsenic (progression of carcinogenesis, altered DNA repair, p53 suppression, altered DNA methylation patterns and gene amplification) do not have as much evidence, particularly from in vivo studies with animals, in vitro studies with human cells, or with human data from case or population studies. Thus, the mode-of-action studies suggest that the arsenic might be acting as a cocarcinogen, a promoter, or a progressor of carcinogenesis (112) .
Various hypotheses have been proposed to explain the carcinigenicity of inorganic arsenic (75) . Nevertheless, molecular mechanisms by which this arsenical induces cancer are still poorly understood. Results of previous studies indicated that inorganic arsenic does not act through classic genotoxic and mutagenic mechanisms, but rather may be a tumor promoter that modifies signal transduction pathways involved in cell growth and proliferation (136) . Inorganic arsenic (III) has been shown to modulate expression and/or DNA-binding activities of several key transcription factors, including nuclear factor kappa B (10), tumor suppressor 53 (p53) (129) , and activating protein-1 (AP-1) (18, 22, 137) . Mechanisms of AP-1 activation by trivalent inorganic arsenic include stimulation of the mitogen-activated protein kinase (MAPK) cascade with a consequent increase in the expression and/or phosphorylation of the two major AP-1 constituents, c-Jun and c-Fos (136) .
In another study, Trouba et al (151) concluded that longterm exposure to high levels of arsenic might make cells more susceptible to mitogenic stimulation and that alterations in mitogenic signaling proteins might contribute to the carcinogenic actions of arsenic. Collectively, several studies (27, 122, 162) have demonstrated that arsenic can interfere with cell signaling pathways (eg, the p53 signaling pathway) that are frequently implicated in the promotion and progression of a variety of tumor types in experimental animal models and of some human tumors.
Clinical trials have found that arsenic has therapeutic value in the treatment of acute promyelocytic leukemia, and there is interest in exploring its effectiveness in the treatment of a variety of other cancers (106, 140) . In acute promyelocytic leukemia, the specific molecular event critical to the formation of malignant cells is known. The study by Puccetti et al (123) found that forced overexpression of BCR-ABL susceptibility in human lymphoblasts cells resulted in greatly enhanced sensitivity to arsenic-induced apoptosis. They also concluded that arsenic is a tumor specific agent capable of inducing apoptosis selectively in acute promyelocytic leukemia cells. Several studies showed that arsenic induces apoptosis through alterations in other cell signaling pathways (4, 135) . In addition to acute peomyelocytic leukemia, arsenic is thought to have therapeutic potential for myeloma (36) . In summary, numerous cancer chemotherapy studies in cell cultures and in patients with acute promyelocytic leukemia and myeloma demonstrate that arsenic can lead to cell-cycle arrest and apoptosis in malignant cells.
Alterations in gene expression via hypo or hypermethylation of CpG sites in DNA have been reviewed (54, 77, 180 ). An important mechanism for altering gene expression in response to both endogenous and exogenous signals, including toxins is altering nuclear transcription factor activities either directly or via specific cell-signaling pathways that regulate them (74) . Several studies have examined p53 gene expression and mutation in tumors obtained from subjects with a history of arsenic ingestion. The p53 participates in many cellular functions, cell-cycle control, DNA repair, differentiation, genomic plasticity and programmed cell death (52, 80, 86) . The tumor suppressor protein p53 is one component of the DNA damage response pathway in mammalian cells. Some of these normal cellular functions of p53 can be modulated and sometimes inhibited by interactions with either cellular proteins (eg, mdm2) or oncoviral proteins of certain DNA viruses. Several different studies support the hypothesis that arsenic can modulate gene expression in humans and experimental models (91, 119, 157) .
SYSTEMIC HEALTH EFFECTS
On the basis of epidemiological studies, ingestion of inorganic arsenic is implicated in noncarcinogenic health effects in various organs or systems including cardiovascular, dermal, reproductive, neurological, respiratory, hepatic, hematological, renal, and gastrointestinal.
Dermatologic Effects: Chronic arsenic exposure causes a characteristic pattern of noncarcinogenic dermal effects that begins with spotted hyper-pigmentation and may later include palmar and plantar hyperkeratosis (101) . Arsenic contamination of well water in Argentina, Chile, India, Taiwan, and Thailand has caused cutaneous skin lesions such as keratosis, and both hyperpigmentation, and hypopigmentation (101) .
The mechanisms for those latter dichotomous effects would be unique and interesting. Characteristic skin lesions of arsenic toxicity may be used as an indicator of high exposure and are distinctive in contrast to other clinical manifestations of arsenic intoxication. Several studies have investigated adverse health effects associated with ingestion of arsenic in groundwater in the Gangetic plain of West Bengal, India and neighboring Bangladesh, where over the past decade more than 30 million people might have been consuming water with arsenic concentrations in excess of 50 µg/L. This study showed a higher prevalence rate of arsenic skin lesions in males than females, with a clear dose-response relationship (31) .
Mazumder et al (101) conducted a cross-sectional survey of the prevalence of hyperpigmentation and palmar-plantar keratosis in a region of West Bengal, India with groundwater arsenic concentrations ranging from nondetectable to 3,400 µg/L. This study found that males were more affected than females for both hyperpigmentation and palmar-plantar keratosis. Several studies found an association between skin lesions and arsenic ingestion in India and Inner Mongolia (156) .
Cardiovascular Effects:
Epidemiological studies have shown that the cardiovascular system is particularly sensitive to long-term ingestion of arsenic in drinking water. Noticeable effects include hypertension and increased cardiovascular disease mortality (113) . Rahman et al (125) conducted a cross-sectional evaluation of blood pressure in 1,595 adults (above 30 years of age) who resided all their life in a rural area of Bangladesh. The area had a high level of arsenic exposure resulting from the use of contaminated groundwater for drinking water; wells were drilled because of microbial contamination of surface water. At the time of this study no subjects were taking antihypertensive medication. The diet, lifestyle, and socioeconomic status of all subjects were similar. The study found that increasing arsenic in drinking water increased the incidence and severity of hypertension (125) .
An increased risk of coronary heart disease has been related to long-term exposure to inorganic arsenic. Blackfoot disease patients have been reported to have increased mortality from ischemic heart disease (ISHD) (28) . Arsenic is a major risk factor for what is known as blackfoot disease, that is peripheral atherosclerosis resulting in dry gangrene and spontaneous amputation of affected extremities. The disease was named for its most striking clinical feature blackish discoloration of the feet or hands (154) . A recent study has reported a biological gradient between cumulative arsenic exposure through consuming artesian well water and lethal ischemic heart disease (ISHD) in Taiwan (24) . Environmental exposure to inorganic arsenic through drinking water has been associated with increased mortality from cardiovascular disease in Chile (176) and Japan (155) , and from cardiovascular disease among chimney sweeps, copper smelter workers, and glass blowers exposed to arsenic in their working environments (66) .
In India, individuals exposed to elevated inorganic arsenic levels in drinking water showed a range of health effects including peripheral vascular disease, noncirrhotic portal fibrosis, nasal septum perforation, bronchitis, and polyneuropathy. In Taiwan, skin pigmentation changes and hyperker-atoses were the most sensitive indicators of inorganic arsenic exposure (101) .
Reproductive and Developmental Effects:
Whereas arsenic exposure has been associated with a number of adverse health outcomes, relatively little attention has been directed toward the potential impact of arsenic on human reproductive system, despite studies in both humans and experimental animals demonstrating that arsenic and its methylated metabolites cross the placenta (34) . Evidence from human studies suggests the potential for adverse reproductive impacts among the offspring of employees and nearby residents of a Swedish copper smelter where arsenic exposure were documented (114) (115) (116) (117) . Female workers gave birth to lower weight infants than women who resided outside the smelter area, and the difference was greater if the mothers worked in the more highly exposed jobs (117) . An incremental trend in the rates of spontaneous abortions was observed with increasing occupational and residential exposure (115, 117) . Congential malformations appeared to be more frequent if the expectant mother was employed in highly exposed jobs during pregnancy (116) . In Bulgaria, the incidence of toxemia of pregnancy and the mortality from congential malformations were significantly higher in an area near a smelter with environmental contamination from various metals than the national rates (178) . Studies of populations exposed to arsenic from drinking water have found increased rates of spontaneous abortions and stillbirths in Hungary (16) and Argentina (21) . In the United States, three studies reported adverse reproductive effects, including increases in mortality from congential cardiovascular anomalies (39, 181) and spontaneous abortions (9) . A study in Texas found an increase in the rates of stillbirths in relation to residential exposures from an arsenic pesticide factory (71) .
Neurological Effects:
In the past, studies of arsenic induced neurological effects have generally focused on central nervous system effects following acute, high-dose intoxication, and on the peripheral neuropathy that occurs following chronic exposure (112) . Two studies have focused on subtle cognitive effects in children following chronic exposure to arsenic. Siripitayakunkit et al (138) investigated the association between environmental arsenic exposure and the intelligence (IQ) of children in the Ronpiboon district of Thailand, where shallow artesian wells were contaminated with arsenic. To prove a significant association between arsenic and growth, head-hair arsenic concentrations and performance on the Weschler Intelligence Scale Test for children (WISTC) in 529 schoolchildren were analysed in a crosssectional evaluation. High arsenic levels measured in hair affect height but not weight. Only 2 epidemiological studies on the effects of arsenic on children's growth exist in the literature. In these studies males were more susceptible than females, and stature was more affected than weight (118, 134) . Anorexia, malabsorption, and weight loss may be present because of low-dose arsenic ingestion (105) . Two follow-up studies of arsenic-poisoned Japanese victims, found that the victim group showed retarded growth from the age of one year to school age with average height of the victims less than that of a same-age group (173) .
A cross-sectional study in San Luis Potosi, Mexico (19) examined the impact of arsenic, lead and under-nutrition on the neuropsychological performance of school children aged 6 to 9 years. Subjects included 41 children living within 1.5 Km of a smelter complex (Morales Zone) with increasing arsenic and lead concentrations, and 39 children living 7 Km upwind from smelter (Martinez Zone). The geometric mean total arsenic concentration in urine was higher in the Morales children than in the Martinez children. Maternal and paternal educational attainment, socioeconomic status was lower in the Martinez group. Neuropsychological performance was assessed using the Weschler Intelligence Scale for children, Revised version, for Mexico (WISC-RM). The Morales children scored significantly lower than the Martinez children on the full-scale IQ test and other neuropsychological subscores (19) .
Respiratory Effects: Noncancer respiratory effects have been reported in populations exposed to arsenic in drinking water (112) , but the database is sparse. Mazumder et al (102) recently reported an association between arsenic ingestion in drinking water and the prevalence of respiratory disorders. Respiratory effects in West Bengal were first noted in 1995 when 57% of the 156 patients who lived in arsenic-affected villages reported having chronic cough (100) . Moreover, epidemiological studies in Chile have previously suggested an association between arsenic and nonmalignant respiratory effects. The survey data collected from 1968 to 1972 in Antofagasta, Chile, Zaldivar, and Ghai (177) reported that the prevalence of cough among 398 children correlated with mean drinking water arsenic concentrations.
Zaldivar (176) also reported that the prevalence of bronchiectasis was 23-fold greater among children with arsenic-induced skin-lesions living in Antofagasta compared to children living in the rest of Chile. A 1976 cross-sectional survey in Antofagasta examined 144 school children with arsenic-induced skin-lesions, and bronchopulmonary disease occurred 2.5 times more often in these children compared to children with normal skin (15) . In a study, Smith et al (139) found high relative rates for chronic obstructive pulmonary disease (COPD) mortality among young men and women living in the same arsenic-exposed region in Chile that includes Antofagasta. A few occupational studies conducted in the 1950s in Sweden have also reported nonmalignant respiratory effects in copper smelter workers exposed to airborne arsenic. In one of the clinical study of copper smelter workers cited by Gerhard et al (46) , a syndrome characterized by lesions of the mucous membranes of the upper respiratory system, emphysema, and decreased pulmonary function, was described (45) .
The relationship between ingested arsenic and nonmalignant respiratory effects has so far only been reported from Chile (30), India (93), and Bangladesh (103) . Studies from arsenic-affected regions in Taiwan, Chile, and Argentina show marked increases in lung cancer mortality. The characteristic feature of arsenic is that it seems to increase both malignant and nonmalignant respiratory disease following ingestion.
Milton et al (103) reported an association between chronic arsenic ingestion and chronic bronchitis in a small crosssectional study of 94 individuals in Bangladesh with arsenicassociated skin lesions. Chronic bronchitis was defined as a history of cough productive of sputum on most days for at least 3 consecutive months for more than 2 successive years, combined with the presence of chest rhonchi and or crepitations on physical examination. Males were at greater risk for chronic bronchitis than the females.
Hepatotoxic Effects: Hernandez-Zavala et al (60) studied liver function in individuals from three towns in the region of Lagunera, Mexico. They determined the serum activity of aspartate aminotransferase (SAT) and alanine aminotransferase (ALT) as indicators of hepatocellular injury and that of gamma-glutamyl-transpeptidase (GGT) and alkaline phosphatase (ALP) as indicators of cholestasic injury. The main findings of this study were predominantly conjugated hyperbilirubinemia and increased serum ALP activity which were related to the concentration of total arsenic in urine, suggesting the presence of cholestasis in arsenic exposed individuals.
Armstrong et al (7) also observed increased concentrations of total bilirubins in serum samples from 7 individuals ingested with arsenic via drinking water. Furthermore, histological examination of livers of individuals chronically exposed to high arsenic concentrations has revealed the presence of portal tract fibrosis, which occasionally causes portal hypertension and bleeding from esophageal varices (99) . In a study by Santra et al (131) , bilirubin or alkaline phosphatase increases were not a characteristic finding in patients with firm hepatomegaly attributed to chronic arsenicosis in West Bengal, India. In that study, liver biopsy results from patients with clinical diagnosis of chronic arsenic poisoning revealed mild portal fibrosis, and cirrhosis. Clinical evidence of portal hypertension (eg, esophageal varices) was uncommon.
Hematologic Effects and Diabetes: Hernandez-Zavala et al (61) studied the activities of some enzymes of the heme biosyntheis pathway and their relationship with the profile of urinary porphyrin excretion in individuals exposed chronically to arsenic via drinking water in Region Lagunera, Mexico. The more evident alterations in heme metabolism observed were: small but significant increases in porphobilinogen deaminase (PBG-D) and uroporphyrinogen decarboxylase (URO-D) activities in peripheral blood erythrocytes; increases in the urinary excretion of total porphyrins, mainly due to coproporphyrin III (COPROIII) and uroporphyrin III (UROIII); and increases in the COPRO/ URO and COPROIII/COPROI ratios. No significant changes were observed in uroporphyrinogen III synthetase (UROIII-S) activity. The direct relationships between enzyme activities and urinary porphyrins, suggest that the increased porphyrin excretion was related to PBG-D, whereas the increased URO-D activity would enhance coproporphyrin synthesis and excretion at the expense of uroporphyrin. None of the human studies available have reported the marked porphyric response and enzyme inhibition observed in rodents.
The main concern of arsenic on the endocrine system is the association between arsenic exposure and diabetes mellitus. As part of an ecological study examining multiple causes of mortality in the area of Southwestern Taiwan where blackfoot disease is endemic, Tsai et al (152) examined mortality from diabetes mellitus in 4 townships, where artesian well water containing arsenic had been consumed from the early 1900s until the mid-to-late 1970s. Diabetes mellitus was listed as the underlying cause of death for 188 males and 343 females.
Tseng et al (153) reported a prospective cohort study examining the incidence of diabetes mellitus in three villages from the arsenic endemic area of Southwestern Taiwan. The study population consisted of three villages where artesian well water (0.70 to 0.93 mg/L As) was used for drinking and cooking until the mid-to-late 1970s. The population was subjected to a follow-up examination that includes fasting blood glucose and an oral glucose tolerance test. The results of this study show an association between long-term arsenic exposure and diabetes mellitus, as found in the previous prevalence study. The prevalence of diabetes mellitus was 2-fold higher in Southwestern area of Taiwan than in Taipei city and the Taiwan area in general (78) .
A dose-response relation between cumulative arsenic exposure and the prevalence of diabetes mellitus was also demonstrated after adjustment for multiple risk factors (78) . Rahman and Axelson (124) carried out a case-control study on Swedish copper smelter workers. Using the death records for 1960-1976, they compared three arsenic exposure categories with an unexposed group. They observed an increased risk of dying from diabetes mellitus with increasing arsenic exposure. In a similar study carried out among art glass workers, indications of a relationship between arsenic exposure and diabetes mellitus have also been reported (126) . In a community-based survey of diabetes mellitus in Bangladesh, Rahman et al (125) observed a dose-response trend between the prevalence of diabetes mellitus and the arsenic level in drinking water.
Renal Effects: The kidneys are the major route of arsenic excretion, as well as a major site of conversion of pentavalent arsenic into the more toxic and less soluble trivalent arsenic. Sites of arsenic damage in the kidney include capillaries, tubules, and glomeruli (133, 141, 168) . As in other organs, capillary damage seems to be a basic event leading to other cellular manifestations. Glomerular arterioles dilate, permitting hematuria. Damaged proximal tubular cells lead to proteinuria and casts in the urine. Mitochondrial damage is also prominent in tubular cells (105) . Oliguria is a common manifestation, but if acute arsenic poisoning is sufficiently severe to produce shock and dehydration, there is real risk of renal failure, although dialysis has been effective in overcoming this complication (48) . Acute cortical necrosis is an uncommon severe renal manifestation, but benefits from dialysis (46) . Arsine-induced hemolysis is likely to cause acute tubular necrosis with partial or complete renal failure, requiring hemodialysis for removal of the hemoglobin-bound arsenic (44, 148) . Recovery may leave interstitial fibrosis and thickened glomerular basement membranes.
Gastrointestinal Effects: The effects of oral ingestion by accident or with suicidal or homicidal intent, the direct effects on the gastrointestinal tract have been prominent and duly noted by several authors (38, 50, 62, 133, 141, 158) . Although arsenic may produce direct irritant effects on gastrointestinal tissues with which it comes in contact, the greatest degree of damage is produced by local submucosal capillary damage from absorbed arsenic (32) . The vascular damage is thought to be the cause of submucosal vesicles, whose rupture can create grossly visible erosions and major fluid and protein loss. Nausea and vomiting can be severe, as can colicky abdominal pain and marked diarrhea. If sufficiently severe, the acute gastroenteritis can lead to circulatory collapse with renal damage and shutdown.
Arsenic poisoning from lesser doses of arsenic may manifest as dry mouth and throat, heartburn, nausea, abdominal pains and cramps, and moderate diarrhea. Chronic low-dose arsenic ingestion may be without symptomatic gastrointestinal irritation or may produce a mild esophagitis, gastritis, or colitis with respective upper and lower abdominal discomfort. Anorexia, malabsorption, and weight loss may be present (105) .
CARCINOGENIC HEALTH EFFECTS
Carcinogenesis is a multistage process involving the inappropriate activation of normal cellular genes to become oncogenes, eg, ras, and the inactivation of other cellular genes called tumor suppressor genes (56) . The prototypic tumor suppressor genes are well suited as a molecular link between the causes of cancer, ie, carcinogenic chemical and physical agents and certain viruses, and the development of clinical cancer. The crucial differences between normal and cancer cells stem from discrete changes in specific genes controlling proliferation and tissue homeostasis (56) . Progress in the fields of molecular carcinogenesis and molecular epidemiology increases our ability to assess cancer risk. Because regulatory decisions based on cancer risk assessments have significant public health and economic consequences, the scientific basis of risk assessment continues to be, and should continue to be, actively investigated (111) .
Long-term exposure to arsenic affects the gastrointestinal tract, circulatory system, skin, liver, lung, kidneys, nervous system, and heart. Evidence from epidemiological studies clearly shows that exposure to inorganic arsenic increases the risk of cancer. In workers exposed by inhalation, the predominant carcinogenic effect is an increased risk of lung cancer (40, 85) , when exposure occurs orally, the main carcinogenic effect is increased risk of skin cancer. In addition to skin cancer, increased risk of several internal cancers (mainly of liver, kidney, lung, colon, and bladder) have been reported with arsenic exposure (147) . In a region of Northern Chile with a history of increased concentrations of arsenic in drinking water, Ferreccio et al (43) conducted a case control study of incident lung cancer in eight public hospitals in regions I, II and III from 1994 through 1996 and frequently matched hospital controls ( Table 1 ). The study identified 152 cases and 419 controls. Historical exposure to arsenic in drinking water for each respondent was estimated by linking residential history information on arsenic concentrations in public water supplies for 40+ years. Odds ratios were used to estimate relative risks of exposure to various concentrations of arsenic in drinking water relative to a reference concentration of 0-10 µg/L. Odd ratios were calculated using unconditional logistic regression, adjusted for age, socioeconomic status, smoking and working in a copper smelter. An association between lung cancer incidences and arsenic concentrations in drinking water was found. Two studies of arsenic exposure and cancer in Chile are also documented. The first, an ecological cohort study, used community estimates of arsenic in water and age-specific ingestion rates (42) . This study found an association between arsenic in drinking water at 50 µg/L and skin cancer as well as 4 internal cancers. The second, a case control study, found an association between bladder cancer and arsenic exposure, as reflected in significant changes in odds ratios with an estimated lifetime cumulative exposure to arsenic (42) .
A prospective cohort study of 8,102 persons was carried out in the Lanyang basin of northeastern Taiwan (29) , a region where arsenic-contaminated shallow wells were used for drinking water over the past 50 years ( Table 2 ). Relative risks were calculated using subjects with exposures <10 µg/L as a reference population. The outcome of the study was a relative risk of total urinary tract cancer incidence (including kidney, bladder and urethral), specifically of the most common cell type of urinary cancer, transitional cell carcinoma (29) .
In the United States, a retrospective cohort mortality study was conducted in Utah based on community estimates of arsenic exposure ( Table 2 ). The results of this study indicated an association between inorganic arsenic and certain cancers as well as noncancer effects. The most predominant types of cancer that were found in the population were bladder and other urinary organ cancers. Males were affected more than the females (87) . A case-control study of skin cancer, in Hungary found an increased risk of basal cell carcinoma associated with elevated levels of atmospheric arsenic from coal combustion. This was particularly apparent in cases diagnosed before 1982 as compared to cases diagnosed after 1986. In addition, the same investigators reported that basal cell carcinomas were associated with elevated occupational exposure to airborne arsenic (1) .
According to an epidemiological study from a blackfoot disease-endemic area of Taiwan, a high mortality was found in males and females for skin, liver, lung, bladder, kidney, and nasal cancers, and possibly other sites. The outcomes of this study corroborate the results of several other studies suggesting a relationship between arsenic exposure and cancers of the internal organs (152) . Arsenic has also been implicated as a bladder carcinogen in separate studies from Argentina, Chile, and Taiwan (13, 63) (Table 3 ). In addition, the results of a study in Cordoba, Argentina add to the evidence that arsenic ingestion increases the risk of kidney cancers (64) . The association between carcinoma of the lung and inhaled arsenic is well established ( Table 4) ; more studies have shown that ingested inorganic arsenic may also be an etiological factor in the development of lung cancer (152) .
Significant excess mortality from cancers of the digestive tract has been observed among copper smelter workers in Anaconda, Montana, with a standardized mortality ratio of 1.3 (41) ; only a slight excess in mortality from digestive tract cancer was observed among smelter workers in Tacoma, Washington (163) . Increased mortality from stomach cancer has been reported among copper smelter workers in Sweden with a standardized mortality ratio of 1.7 (92) , and among Moselle vinters with a standardized mortality ratio of 2.4 (150) . Colon cancer mortality has also been significantly associated with chronic exposures to inorganic arsenic among copper smelter workers in Tacoma, Washington, with a significant standardized mortality ratio of 2.1 for those who employed before respirators were implemented in the smelter (41) , and among smelter workers in Japan with a standardized mortality ratio of 5.1 (25) .
There was no apparent increase in stomach cancer mortality among residents in the area of endemic blackfoot disease in Taiwan, but significantly increased colon cancer mortality, with a standardized mortality ratios of 1.6 for men and 1.7 for women, was observed in the area (25) .
CONCLUSIONS
Integration of the available scientific information on arsenic indicates that geogenic and anthropogenic contamination of natural resources represents a major public health problem in many countries of the world. Exposure to arsenic occurs via ingestion, inhalation, and dermal contact. Such exposure has been associated with a significant number of systemic health effects in various organs and tissue systems including skin, lung, liver, kidney, bladder, gastrointestinal tract, respiratory system, and hematopoetic system. Evidence from recent studies has linked arsenic consumption in drinking water with two non-cancer health conditions (hypertension and diabetes mellitus) that are a major cause of morbidity and mortality. A small number of studies have investigated the relationship between arsenic exposure in humans and adverse reproductive effects, including studies of populations in Chile and Bangladesh exposed to increased concentrations of arsenic in drinking water. There is some evidence from these studies that arsenic increases stillbirths, spontaneous abortions, preterm births, and infant mortality. Findings from a large prevalence study in West Bengal, a small prevalence study in Bangladesh, and an ecological mortality study in the area of Southwestern Taiwan where arsenic is endemic indicated an association between arsenic ingestion and non-cancer respiratory effects. Two recent investigations of neurocognitive function in young schoolchildren suggest that arsenic exposure might be associated with an (IQ) adverse effect. Experiments in animals and in vitro have demonstrated that arsenic has many biochemical and cytotoxic effects at low doses of human exposure. Those effects include induction of oxidative damage, altered DNA methylation and gene expression; changes in intracellular levels of mdm2 protein and p53 protein; inhibition of thioredoxin reductase; inhibition of pyruvate dehydrogenase; altered colony-forming efficiency; induction of protein-DNA cross-links; induction of apoptosis; altered regulation of DNA-repair genes, thioredoxin, glutathione reductase, and other stress-response pathways; stimulation or inhibition of normal human keratinocyte proliferation, depending on the concentration; and altered function of the glucocorticoid receptor. Additionally, the evidence of carcinogenicity in humans is very strong, especially for cancer of the skin, lung, liver, kidney, and bladder.
Further epidemiological studies are highly recommended to investigate the dose-response relationship btween arsenic ingestion and noncancer endpoints. Because of the very large populations exposed, these endpoints are common causes of morbidity and mortality, even small increases in relative risk at low doses of arsenic exposure could be of considerable public-health significance. Such information is also important in developing a comprehensive risk assessment and management program for arsenic.
